GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

VIP peptides [Cleaved into: Intestinal peptide PHI-42; Intestinal peptide PHI-27 (Peptide histidine isoleucinamide 27); Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)]

 VIP_MOUSE               Reviewed;         170 AA.
P32648; Q9D2Z7; Q9QUN1;
01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
01-OCT-1993, sequence version 1.
13-FEB-2019, entry version 134.
RecName: Full=VIP peptides;
Contains:
RecName: Full=Intestinal peptide PHI-42;
Contains:
RecName: Full=Intestinal peptide PHI-27;
AltName: Full=Peptide histidine isoleucinamide 27;
Contains:
RecName: Full=Vasoactive intestinal peptide;
Short=VIP;
AltName: Full=Vasoactive intestinal polypeptide;
Flags: Precursor;
Name=Vip;
Mus musculus (Mouse).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
Muroidea; Muridae; Murinae; Mus; Mus.
NCBI_TaxID=10090;
[1]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=1851524; DOI=10.1016/0169-328X(91)90005-I;
Lamperti E.D., Rosen K.M., Villa-Komaroff L.;
"Characterization of the gene and messages for vasoactive intestinal
polypeptide (VIP) in rat and mouse.";
Brain Res. Mol. Brain Res. 9:217-231(1991).
[2]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
STRAIN=C57BL/6J; TISSUE=Cecum;
PubMed=16141072; DOI=10.1126/science.1112014;
Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
Hayashizaki Y.;
"The transcriptional landscape of the mammalian genome.";
Science 309:1559-1563(2005).
[3]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Pituitary;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[4]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-36.
STRAIN=C57BL/6J; TISSUE=Spleen;
PubMed=7894056; DOI=10.3109/10425179409039701;
Sena M., Bravo D.T., Agoston D., Waschek J.A.;
"High conservation of upstream regulatory sequences on the human and
mouse vasoactive intestinal peptide (VIP) genes.";
DNA Seq. 5:25-29(1994).
[5]
PROTEIN SEQUENCE OF 119-129 AND 134-152, AND AMIDATION AT ASN-152.
TISSUE=Mast cell;
PubMed=8402943; DOI=10.1006/cimm.1993.1246;
Wershil B.K., Turck C.W., Sreedharan S.P., Yang J., An S., Galli S.J.,
Goetzl E.J.;
"Variants of vasoactive intestinal peptide in mouse mast cells and rat
basophilic leukemia cells.";
Cell. Immunol. 151:369-378(1993).
-!- FUNCTION: VIP causes vasodilation, lowers arterial blood pressure,
stimulates myocardial contractility, increases glycogenolysis and
relaxes the smooth muscle of trachea, stomach and gall bladder.
-!- FUNCTION: PHM-27 is a potent agonist of the calcitonin receptor
CALCR, with similar efficacy as calcitonin (By similarity). PHM
also causes vasodilation. {ECO:0000250}.
-!- SUBCELLULAR LOCATION: Secreted.
-!- SIMILARITY: Belongs to the glucagon family. {ECO:0000305}.
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; AK018599; BAB31301.1; -; mRNA.
EMBL; BC089511; AAH89511.1; -; mRNA.
EMBL; X74297; CAA52350.1; -; Genomic_DNA.
PIR; A60037; A60037.
RefSeq; NP_001300898.1; NM_001313969.1.
RefSeq; NP_035832.1; NM_011702.3.
RefSeq; XP_006512510.1; XM_006512447.1.
UniGene; Mm.98916; -.
ProteinModelPortal; P32648; -.
SMR; P32648; -.
STRING; 10090.ENSMUSP00000019906; -.
PhosphoSitePlus; P32648; -.
PaxDb; P32648; -.
PRIDE; P32648; -.
GeneID; 22353; -.
KEGG; mmu:22353; -.
UCSC; uc007egk.1; mouse.
CTD; 7432; -.
MGI; MGI:98933; Vip.
eggNOG; ENOG410IW68; Eukaryota.
eggNOG; ENOG4111JKK; LUCA.
HOGENOM; HOG000253943; -.
HOVERGEN; HBG018069; -.
InParanoid; P32648; -.
KO; K05264; -.
OrthoDB; 1343108at2759; -.
PhylomeDB; P32648; -.
TreeFam; TF332804; -.
PRO; PR:P32648; -.
Proteomes; UP000000589; Unplaced.
GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
GO; GO:0043005; C:neuron projection; IBA:GO_Central.
GO; GO:0043025; C:neuronal cell body; ISO:MGI.
GO; GO:0043204; C:perikaryon; IBA:GO_Central.
GO; GO:0005179; F:hormone activity; IDA:BHF-UCL.
GO; GO:0005184; F:neuropeptide hormone activity; IBA:GO_Central.
GO; GO:0051428; F:peptide hormone receptor binding; ISO:MGI.
GO; GO:0005102; F:signaling receptor binding; ISO:MGI.
GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IDA:BHF-UCL.
GO; GO:0048242; P:epinephrine secretion; IBA:GO_Central.
GO; GO:0007611; P:learning or memory; ISO:MGI.
GO; GO:0048255; P:mRNA stabilization; ISS:AgBase.
GO; GO:0043066; P:negative regulation of apoptotic process; ISO:MGI.
GO; GO:0043267; P:negative regulation of potassium ion transport; ISO:MGI.
GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; ISO:MGI.
GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
GO; GO:0097755; P:positive regulation of blood vessel diameter; ISO:MGI.
GO; GO:0001938; P:positive regulation of endothelial cell proliferation; ISO:MGI.
GO; GO:0032812; P:positive regulation of epinephrine secretion; IBA:GO_Central.
GO; GO:0060406; P:positive regulation of penile erection; ISO:MGI.
GO; GO:0045732; P:positive regulation of protein catabolic process; IDA:BHF-UCL.
GO; GO:0070459; P:prolactin secretion; ISS:AgBase.
GO; GO:0032880; P:regulation of protein localization; IDA:BHF-UCL.
GO; GO:0051930; P:regulation of sensory perception of pain; ISO:MGI.
GO; GO:0009966; P:regulation of signal transduction; IMP:MGI.
InterPro; IPR000532; Glucagon_GIP_secretin_VIP.
InterPro; IPR015523; VIP.
PANTHER; PTHR11213:SF5; PTHR11213:SF5; 1.
Pfam; PF00123; Hormone_2; 2.
SMART; SM00070; GLUCA; 2.
PROSITE; PS00260; GLUCAGON; 2.
1: Evidence at protein level;
Amidation; Cleavage on pair of basic residues; Complete proteome;
Direct protein sequencing; Glycoprotein; Hormone; Phosphoprotein;
Reference proteome; Secreted; Signal.
SIGNAL 1 21 {ECO:0000250}.
PROPEP 22 79
/FTId=PRO_0000011462.
PEPTIDE 81 122 Intestinal peptide PHI-42. {ECO:0000250}.
/FTId=PRO_0000011463.
PEPTIDE 81 107 Intestinal peptide PHI-27.
/FTId=PRO_0000011464.
PEPTIDE 125 152 Vasoactive intestinal peptide.
/FTId=PRO_0000011465.
PROPEP 156 170
/FTId=PRO_0000011466.
MOD_RES 76 76 Phosphoserine.
{ECO:0000250|UniProtKB:P01283}.
MOD_RES 107 107 Isoleucine amide. {ECO:0000250}.
MOD_RES 152 152 Asparagine amide.
{ECO:0000269|PubMed:8402943}.
CARBOHYD 133 133 N-linked (GlcNAc...) asparagine.
{ECO:0000255}.
CONFLICT 35 35 V -> VS (in Ref. 2 and 3). {ECO:0000305}.
CONFLICT 122 122 I -> V (in Ref. 5; AA sequence).
{ECO:0000305}.
SEQUENCE 170 AA; 19049 MW; 0164C831F8F5C73D CRC64;
MEARSKPQFL AFLILFSVLF SQSLAWPLFG PPSVVRLDDR MPFEGAGDPD QVSLKADSDI
LQNPLAENGT PYYDVSRNAR HADGVFTSDY SRLLGQISAK KYLESLIGKR ISSSISEDPV
PIKRHSDAVF TDNYTRLRKQ MAVKKYLNSI LNGKRSSEGD SADFLEELEK


Related products :

Catalog number Product name Quantity
PEPA41T RABBIT ANTI PIG VASOACTIVE INTESTINAL PEPTIDE, Product Type Polyclonal Antibody, Specificity VASOACTIVE INTESTINAL PEPTIDE, Target Species Pig, Host Rabbit, Format Serum, Isotypes Polyclonal IgG 20 µl
SCH-PEPA41T RABBIT ANTI PIG VASOACTIVE INTESTINAL PEPTIDE, Product Type Polyclonal Antibody, Specificity VASOACTIVE INTESTINAL PEPTIDE, Target Species Pig, Host Rabbit, Format Serum, Isotypes Polyclonal IgG 20 µl
9535-0204 RABBIT ANTI VASOACTIVE INTESTINAL PEPTIDE, Product Type Polyclonal Antibody, Specificity VASOACTIVE INTESTINAL PEPTIDE, Target Species Human, Host Rabbit, Format Purified, Isotypes Polyclonal Ig 0.5 ml
SCH-9535-0204 RABBIT ANTI VASOACTIVE INTESTINAL PEPTIDE, Product Type Polyclonal Antibody, Specificity VASOACTIVE INTESTINAL PEPTIDE, Target Species Human, Host Rabbit, Format Purified, Isotypes Polyclonal Ig 0.5 ml
U0380c CLIA Canis familiaris,Canis lupus familiaris,Dog,Vasoactive intestinal peptide,Vasoactive intestinal polypeptide,VIP,VIP 96T
E0380c ELISA Canis familiaris,Canis lupus familiaris,Dog,Vasoactive intestinal peptide,Vasoactive intestinal polypeptide,VIP,VIP 96T
E0380c ELISA kit Canis familiaris,Canis lupus familiaris,Dog,Vasoactive intestinal peptide,Vasoactive intestinal polypeptide,VIP,VIP 96T
orb72032 Vasoactive Intestinal peptide This is Vasoactive Intestinal peptide. For research use only. 1 mg
AE6302AG.1 Vasoactive Intestinal Peptide-Receptor 2 (VIP-R2) antigen: human Vasoactive Intestinal Peptide-Receptor 2 100
AE6302AG.2 Vasoactive Intestinal Peptide-Receptor 2 (VIP-R2) antigen: human Vasoactive Intestinal Peptide-Receptor 2 1 mg
orb72033 Vasoactive Intestinal Constractor [VIC] peptide This is Vasoactive Intestinal Constractor [VIC] peptide. For research use only. 1 mg
orb72031 Vasoactive Intestinal Contractor [VIC] peptide This is Vasoactive Intestinal Contractor [VIC] peptide. For research use only. 1 mg
bs-0077P Peptides: VIP (Vasoactive Intestinal peptide) Protein Length:12-25 amino acids. 200ug lyophilized
AE6302AG.1 human Vasoactive Intestinal Peptide-Receptor 2 form: Synthetic peptide 100
064-10 Vasoactive Intestinal Peptide (VIP)(PHM)(111_122) _Prepro (PHM_VIP Space Peptide) _ 500ug 500 µg
AE6302AG.2 human Vasoactive Intestinal Peptide-Receptor 2 form: Synthetic peptide 1 mg
VIPR11-P Mouse Vasoactive intestinal peptide receptor (VIPR1_VPAC1) Control_blocking peptide 1 100 ug
VIPR21-P Rat Vasoactive intestinal peptide receptor (VIPR2_VPAC2) Control_blocking peptide 1 100 ug
VIP16-P Mouse Vasoactive intestinal peptide (VIP) Control blocking peptide #1 100 ug
VIPRRP11-P Rat Vasoactive intestinal peptide receptor_gene repressor protein (VIPRRP) Control_blocking peptide 1 100 ug
VIPR21-P Rat Vasoactive intestinal peptide receptor (VIPR2 VPAC2) Control blocking peptide #1 100 ug
VIPR11-P Mouse Vasoactive intestinal peptide receptor (VIPR1 VPAC1) Control blocking peptide #1 100 ug
VIP16-P Mouse Vasoactive intestinal peptide (VIP) Control_blocking peptide 1 100 ug
VIPRRP11-P Rat Vasoactive intestinal peptide receptor-gene repressor protein (VIPRRP) Control blocking peptide #1 100 ug
5-43235 Vasoactive Intestinal peptide, peptide reagents 2.5 mg

Kits Elisa; taq POLYMERASE

Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur



Quick order!
Enter catalog number :


Gentaur; yes we can

Pathways :
WP1001: Peptide GPCRs
WP1117: Peptide GPCRs
WP131: Peptide GPCRs
WP1338: Peptide GPCRs
WP234: Peptide GPCRs
WP24: Peptide GPCRs
WP771: Peptide GPCRs
WP883: Peptide GPCRs
WP1581: Histidine metabolism
WP2185: Purine metabolism
WP416: Superpathway of Histidine, Purine, and Pyrimidine
WP514: Histidine Biosynthesis

Related Genes :
[Vip] VIP peptides [Cleaved into: Intestinal peptide PHI-42; Intestinal peptide PHI-27 (Peptide histidine isoleucinamide 27); Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)]
[Vip] VIP peptides [Cleaved into: Intestinal peptide PHV-42; Intestinal peptide PHI-27 (Peptide histidine isoleucinamide 27); Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)]
[VIP] VIP peptides [Cleaved into: Intestinal peptide PHI-27 (Peptide histidine isoleucinamide 27); Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)] (Fragment)
[VIP] VIP peptides [Cleaved into: Intestinal peptide PHI-27 (Peptide histidine isoleucinamide 27); Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)]
[VIP] VIP peptides [Cleaved into: Intestinal peptide PHV-42 (Peptide histidine valine 42); Intestinal peptide PHM-27 (Peptide histidine methioninamide 27); Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)]
[VIP] VIP peptides [Cleaved into: Intestinal peptide PHI-27-like; Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)]
[VIPR1] Vasoactive intestinal polypeptide receptor 1 (VIP-R-1) (Pituitary adenylate cyclase-activating polypeptide type II receptor) (PACAP type II receptor) (PACAP-R-2) (PACAP-R2) (VPAC1)
[GCG] Glucagon [Cleaved into: Glicentin; Glicentin-related polypeptide (GRPP); Oxyntomodulin (OXM) (OXY); Glucagon; Glucagon-like peptide 1 (GLP-1) (Incretin hormone); Glucagon-like peptide 1(7-37) (GLP-1(7-37)); Glucagon-like peptide 1(7-36) (GLP-1(7-36)); Glucagon-like peptide 2 (GLP-2)]
[GUCY2C GUC2C STAR] Heat-stable enterotoxin receptor (STA receptor) (hSTAR) (EC 4.6.1.2) (Guanylyl cyclase C) (GC-C) (Intestinal guanylate cyclase)
[] Bradykinin-potentiating and C-type natriuretic peptides (Brain BPP-CNP) (bBPP-CNP) (Evasin-CNP) [Cleaved into: Bradykinin-potentiating peptide 13a+QQWA (BPP-13a+QQWA); Bradykinin-potentiating peptide 13a+QWA (BPP-13a+QWA); Bradykinin-potentiating peptide 13a (BPP-13a); Bradykinin-potentiating peptide 10c+QQWA (BPP-10c+QQWA); Bradykinin-potentiating peptide 10c (BPP-10c) (BPP-2) (Evasin-10c); Bradykinin-potentiating peptide 12b (BPP-12b) (Evasin-12b); Bradykinin-potentiating peptide AP; Bradykinin-potentiating peptide APL (BPP-APL); Bradykinin-potentiating peptide 11e (BPP-11e) (Evasin-11e); Bradykinin-potentiating peptide 5a (BPP-5a) (Bradykinin-potentiating peptide Va) (BPPVa) (Evasin-5a) (Proline-rich peptide 5a) (Bj-PRO-5a) (PRO-5a); Poly-His-poly-Gly peptide 1 (pHpG-1); C-type natriuretic peptide (Bj-CNP)]
[TFF3 ITF TFI] Trefoil factor 3 (Intestinal trefoil factor) (hITF) (Polypeptide P1.B) (hP1.B)
[] Bradykinin-potentiating and C-type natriuretic peptides (BPP-CNP) [Cleaved into: Bradykinin-potentiating peptide 6a (BPP-6a); Bradykinin-potentiating peptide 10a (BPP-10a) (Bradykinin-potentiating peptide IV-1-A) (BPPIV-1-A) (Bradykinin-potentiating peptide V-8); Bradykinin-potentiating peptide 13a+QQWA (BPP-13a+QQWA); Bradykinin-potentiating peptide 13a+QWA (BPP-13a+QWA); Bradykinin-potentiating peptide 13a (BPP-13a) (Bradykinin-potentiating peptide III-1-A) (III-1-A) (Bradykinin-potentiating peptide V-9); Bradykinin-potentiating peptide 10c+QQWA (BPP-10c+QQWA); Bradykinin-potentiating peptide 10c (BPP-10c) (BPP-2) (Bradykinin-potentiating peptide IV-1-Bbeta) (BPP IV-1-Bbeta) (Bradykinin-potentiating peptide V-7); Bradykinin-potentiating peptide 10c-F (BPP-10c-F); Bradykinin-potentiating peptide 11b (BPP-11b) (Bradykinin-potentiating peptide IIa) (BPP-IIa); Bradykinin-potentiating peptide IIb (BPP-IIb); Bradykinin-potentiating peptide 5a (BPP-5a) (Bradykinin-potentiating peptide Va) (BPPVa) (Proline-rich peptide 5a) (Bj-PRO-5a) (PRO-5a); Poly-His-poly-Gly peptide 1 (pHpG-1); C-type natriuretic peptide (Bj-CNP)]
[] Bradykinin-potentiating and C-type natriuretic peptides (Angiotensin-converting enzyme inhibitor) (BPP-CNP homolog) [Cleaved into: Bradykinin-potentiating peptide 13a (BPP-13a) (Bradykinin-potentiating peptide S3,1); Bradykinin-potentiating peptide 10c (BPP-10c) (BPP-2) (Bradykinin-potentiating peptide S4,3,1); Bradykinin-potentiating peptide 12b (BPP-12b) (Bradykinin-potentiating peptide S4,3,2); Bradykinin-potentiating peptide 11e (BPP-11e); Bradykinin-potentiating peptide 5a (BPP-5a) (Bradykinin-potentiating peptide S5,2) (Bradykinin-potentiating peptide Va) (BPPVa) (Proline-rich peptide 5a) (PRO-5a); C-type natriuretic peptide (CNP)]
[] Bradykinin-potentiating and C-type natriuretic peptides (Angiotensin-converting enzyme inhibitor) (BPP-CNP homolog) [Cleaved into: Blomhotin; Bradykinin-potentiating peptide A (BPP-a) (Potentiator A); Leu3-blomhotin (Potentiator D); Bradykinin-potentiating peptide B (BPP-b) (Potentiator B); Bradykinin-potentiating peptide C (BPP-c) (Potentiator C); Bradykinin-potentiating peptide E (BPP-e) (Potentiator E); Bradykinin-potentiating peptide Ahb1 (BPP-Ahb1); Bradykinin-potentiating peptide Ahb2 (BPP-Ahb2); C-type natriuretic peptide]
[] Bradykinin-potentiating and C-type natriuretic peptides (BPP-CNP) [Cleaved into: Bradykinin-potentiating peptide 1 (BPP 1); Bradykinin-potentiating peptide 2 (BPP 2); Bradykinin-potentiating peptide 3 (BPP 3); Bradykinin-potentiating peptide 4 (BPP 4); Bradykinin-potentiating peptide 5 (BPP 5); Bradykinin inhibitor peptide (BIP); C-type natriuretic peptide (CNP)]
[gag] Gag polyprotein [Cleaved into: Matrix protein p19; p2A; p2B; p10; Capsid protein p27, alternate cleaved 1; Capsid protein p27, alternate cleaved 2; Spacer peptide (SP) (p3); Nucleocapsid protein p12; Protease p15 (EC 3.4.23.-)]
[GCG] Glucagon [Cleaved into: Glicentin-related polypeptide (GRPP); Glucagon; Glucagon-like peptide 1 (GLP-1); Glucagon-like peptide 1(7-37) (GLP-1(7-37)); Glucagon-like peptide 1(7-36) (GLP-1(7-36)); Glucagon-like peptide 2 (GLP-2)]
[VIP EGK_15243] VIP peptides isoform 1 preproprotein (Vasoactive intestinal peptide)
[vip] Vasoactive intestinal peptide
[gag-pol] Gag-Pol polyprotein [Cleaved into: Matrix protein p19; p2A; p2B; p10; Capsid protein p27, alternate cleaved 1; Capsid protein p27, alternate cleaved 2; Spacer peptide (SP) (p3); Nucleocapsid protein p12; Protease p15 (EC 3.4.23.-); Reverse transcriptase, beta-subunit (RT-beta); Reverse transcriptase, alpha-subunit (RT-alpha) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (pp32); p4]
[SI] Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]
[PDZD3 IKEPP NHERF4 PDZK2 DLNB27] Na(+)/H(+) exchange regulatory cofactor NHE-RF4 (NHERF-4) (Intestinal and kidney-enriched PDZ protein) (Natrium-phosphate cotransporter IIa C-terminal-associated protein 2) (Na/Pi cotransporter C-terminal-associated protein 2) (NaPi-Cap2) (PDZ domain-containing protein 2) (PDZ domain-containing protein 3) (Sodium-hydrogen exchanger regulatory factor 4)
[vip vip1] Vasoactive intestinal polypeptide type I
[MUC17 MUC3] Mucin-17 (MUC-17) (Small intestinal mucin-3) (MUC-3)
[GHRL MTLRP UNQ524/PRO1066] Appetite-regulating hormone (Growth hormone secretagogue) (Growth hormone-releasing peptide) (Motilin-related peptide) (Protein M46) [Cleaved into: Ghrelin-27; Ghrelin-28 (Ghrelin); Obestatin]
[Itln1 Intl Itln Itln1a Itlna] Intelectin-1a (Galactofuranose-binding lectin) (Intestinal lactoferrin receptor)
[vip] Histidine-isoleucine/vasoactive intestinal polypeptide
[VIP CK820_G0037876] VIP isoform 2 (Vasoactive intestinal peptide)
[pept-1 cptb opt-2 pep-2 K04E7.2] Peptide transporter family 1 (Di-/tri-peptide transporter CPTB) (Oligopeptide transporter 1)
[Ptk6 Sik] Protein-tyrosine kinase 6 (EC 2.7.10.2) (SRC-related intestinal kinase)

Bibliography :
[20800633] Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells.
[16888226] Cyclic AMP formation in C6 glioma cells: effect of PACAP and VIP in early and late passages.
[8933357] Tissue specific expression of different human receptor types for pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide: implications for their role in human physiology.
[8275932] Pituitary adenylate cyclase-activating polypeptide regulation of AtT-20/D16v corticotrope cell proopiomelanocortin expression and secretion.
[2474355] Actions of constrictor (NPY and endothelin) and dilator (substance P, CGRP and VIP) peptides on pig splenic and human skeletal muscle arteries: involvement of the endothelium.
[2469109] Effects of growth hormone releasing factor on pancreatic secretion in vivo and in vitro.